Previous close | 11.73 |
Open | 13.22 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 12.98 - 13.22 |
52-week range | 12.98 - 13.22 |
Volume | 449 |
Avg. volume | N/A |
Market cap | N/A |
Beta (5Y monthly) | 0.50 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.46 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
The call will also be available for replay on Anavex's website at www.anavex.com. With us today is Dr. Christopher Missling, president and chief executive officer; and Sandra Boenisch, principal financial officer.
Deciphera Pharmaceuticals (DCPH) reports narrower-than-expected loss. Nonetheless, sales marginally surpass estimates for the fourth quarter of 2020.
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...